HD HTT

Disease ID
HD
Gene ID
HTT
Updated
May 15, 2026
v2.20.0
Suggest Edit

Disease

Name
Huntington disease
Inheritance
Autosomal dominant
Description
Huntington disease (HD) is a rare neurodegenerative disorder of the central nervous system characterized by unwanted choreatic movements, behavioral and psychiatric disturbances and dementia1 .
Prevalence
1 10,000
6.5-15/100,0002 . 9.71-17:100,000 (European) vs. 0.1-2/100,000 (African), as many as 1 in 400 have reduced penetrance (0.2-2% for 36-38 CAG) HTT alleles3 . Found across ethnicities/ancestries, with population-dependent prevalence3 .
Age of Onset(Typical)Years1  8535  44
Age of Onset Details
Typical: 35-443 ; Range: 1-854,5 .

Locus

Details
27-35 motifs are unstable/premutations, while 36-39 motifs are associated with reduced penetrance and mild phenotypes6 , and alleles over 40 repeats are typically fully penetrant3 . >60 motifs associated with onset age <20 years3 . Only CAG expansions are considered pathogenic, but interruptions impact pathogenicity (CAA)7,8 . Only fathers with premutations are considered at risk of transmitting pathogenic alleles9 . CAG repeat size 21-35 may continuously modulate brain structure and psychiatric disease risk in an age-dependent manner6 . Somatic expansion of HTT CAG repeats in vulnerable tissues is proposed to contribute to age-dependent onset and neurodegeneration, with greater repeat instability associated with earlier disease onset10,11 . Undiagnosed carriers of premutation and pathogenic HTT expansions, exhibit reduced striatal brain volumes and elevated neurofilament light chain levels before clinical diagnosis, consistent with findings observed across other loci12 .
Mechanism
GoF/LoF
While the primary pathogenic mechanism is gain of function of the protein product, pathogenesis is complex and multifactorial13 . Reduced SCN4B expression in striatal neurons has been implicated as a modifier of HD-associated phenotype severity, potentially contributing to dysfunction in motor associated striatal neuronal populations14 .
Year
199315
Location in Gene
Coding Exon 1
Gene Strand

Alleles

Ref. Motif
CAG
Pathogenic (ref.)
CAG
Pathogenic (gene)
AGC
Interruption (ref.)
CAA
Interruption (gene)
AAC
BenignIntermediatePathogenicUnits6  2627  3536  250

gnomAD

References

Direct supporting references for info on this page.

1
Ontology Lookup Service (OLS)
mondo:0007739
2
Profiling of Short-Tandem-Repeat Disease Alleles in 12,632 Human Whole Genomes.
Haibao,Tang, Ewen F,Kirkness, Christoph,Lippert, William H,Biggs, Martin,Fabani, Ernesto,Guzman, Smriti,Ramakrishnan, Victor,Lavrenko, Boyko,Kakaradov, Claire,Hou, Barry,Hicks, David,Heckerman, Franz J,Och, C Thomas,Caskey, J Craig,Venter, Amalio,Telenti
American journal of human genetics · 2017-11-02
pmid:29100084
4
Expanding the Phenotype of Extremely Early Onset Juvenile Huntington's Disease: A Case Report and Review of Previously Published Cases.
Zöe,Powis, Jonathon,Lutz, Khalida,Liaquat, Jyes A,Querubin, Sat Dev,Batish
American journal of medical genetics. Part A · 2024-10-23
pmid:39441074
5
Huntington's disease: a clinical review.
Raymund A C,Roos
Orphanet journal of rare diseases · 2010-12-20
pmid:21171977
6
Huntingtin CAG repeat size variations below the Huntington's disease threshold: associations with depression, anxiety and basal ganglia structure.
Magdalena,Vater, Nicolas,Rost, Gertrud,Eckstein, Susann,Sauer, Alina,Tontsch, Angelika,Erhardt, Susanne,Lucae, Tanja,Brückl, Thomas,Klopstock, Philipp G,Sämann, Elisabeth B,Binder
European journal of human genetics : EJHG · 2024-11-21
pmid:39572770
7
Comprehensive genetic diagnosis of tandem repeat expansion disorders with programmable targeted nanopore sequencing.
Igor,Stevanovski, Sanjog R,Chintalaphani, Hasindu,Gamaarachchi, James M,Ferguson, Sandy S,Pineda, Carolin K,Scriba, Michel,Tchan, Victor,Fung, Karl,Ng, Andrea,Cortese, Henry,Houlden, Carol,Dobson-Stone, Lauren,Fitzpatrick, Glenda,Halliday, Gianina,Ravenscroft, Mark R,Davis, Nigel G,Laing, Avi,Fellner, Marina,Kennerson, Kishore R,Kumar, Ira W,Deveson
Science advances · 2022-03-04
pmid:35245110
8
When repetita no-longer iuvant: somatic instability of the CAG triplet in Huntington's disease.
Elena,Cattaneo, Davide,Scalzo, Martina,Zobel, Raffaele,Iennaco, Camilla,Maffezzini, Dario,Besusso, Simone,Maestri
Nucleic acids research · 2025-01-07
pmid:39673793
9
Estimating the probability of de novo HD cases from transmissions of expanded penetrant CAG alleles in the Huntington disease gene from male carriers of high normal alleles (27-35 CAG).
Audrey E,Hendricks, Jeanne C,Latourelle, Kathryn L,Lunetta, L Adrienne,Cupples, Vanessa,Wheeler, Marcy E,MacDonald, James F,Gusella, Richard H,Myers
American journal of medical genetics. Part A · 2009-07-01
pmid:19507258
13
Huntington's Disease: Mechanisms of Pathogenesis and Therapeutic Strategies.
Maria,Jimenez-Sanchez, Floriana,Licitra, Benjamin R,Underwood, David C,Rubinsztein
Cold Spring Harbor perspectives in medicine · 2017-07-05
pmid:27940602
15
A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group.
Cell · 1993-03-26
pmid:8458085

Additional Literature

Additional literature related to this locus.

Raw PubMed search results
(All PubMed results returned by searching for this gene, tandem repeats, and disease, in medline format)

10
Extensive transcriptomic changes in cellular and animal models of Huntington's disease depending on the length of CAG repeats in the exon 1 of the HTT gene.
Aneta,Szulc, Beata M,Walter, Lidia,Gaffke, Karolina,Wiśniewska, Magdalena,Żabińska, Estera,Rintz, Zuzanna,Cyske, Michał,Grabski, Oleksandr,Pankiv, Magdalena,Podlacha, Karolina,Pierzynowska, Grzegorz,Węgrzyn
Biochemical and biophysical research communications · 2026-04-01
pmid:41926793
11
Long somatic DNA-repeat expansion drives neurodegeneration in Huntington's disease.
Robert E,Handsaker, Seva,Kashin, Nora M,Reed, Steven,Tan, Won-Seok,Lee, Tara M,McDonald, Kiely,Morris, Nolan,Kamitaki, Christopher D,Mullally, Neda R,Morakabati, Melissa,Goldman, Gabriel,Lind, Rhea,Kohli, Elisabeth,Lawton, Marina,Hogan, Kiku,Ichihara, Sabina,Berretta, Steven A,McCarroll
Cell · 2025-01-16
pmid:39824182
12
Population-scale repeat expansions elucidate disease risk and brain atrophy.
Vijay Kumar,Pounraja, Jae Hoon,Sul, Joseph,Herman, Sean,O'Keeffe, Veera,Rajagopal, Xiaodong,Bai, Michael D,Kessler, Neelroop,Parikshak, Karl,Landheer, Xingmin,Zhang, Sean,Yu, Lance,Zhang, Michelle G,LeBlanc, Jennifer,Rico-Varela, Frederic,Grau, Sarah,Wolf, Sriramkumar,Sundaramoorthy, Farshid,Sepehrband, Eli A,Stahl, Yuda,Huo, Mohsin,Ahmed, Susan,Croll, William,Salerno, John D,Overton, Jonathan,Marchini, Jeffrey,Reid, Luca A,Lotta, Aris,Baras, Goncalo R,Abecasis, Giovanni,Coppola, Sahar,Gelfman
Nature · 2026-04-08
pmid:41951733
14
Scn4b Modulates Huntington's Disease Phenotype Severity in vivo.
Suphinya,Sathitloetsakun, Vanessa,Farrell, S Sebastian,Pineda, Hyeseung,Lee, Jung Hoon,Shin, Francisco J,Garcia, Raleigh M,Linville, Manolis,Kellis, Veronica A,Alvarez, Myriam,Heiman
bioRxiv : the preprint server for biology · 2026-03-10
pmid:41959367
Towards AI-driven prediction of
Simone,Maestri, Davide,Scalzo, Martina,Zobel, Dario,Besusso, Elena,Cattaneo
Journal of Huntington's disease · 2026-04-20
pmid:42007924
Unraveling the genetic architecture of non-Huntington chorea: a biobank-scale study of rare variants and repeat expansions.
Fulya,Akçimen, Monica,Diez-Fairen, Ignacio,Alvarez, Victor,Puente, Spencer,Grant, Jorge,Hernandez-Vara, Marzieh,Khani, Mariateresa,Buongiorno, Félix Javier,Jiménez-Jiménez, José A G,Agúndez, Miquel,Aguilar, Esther,Cubo, Jesus,Perez, Javier,Pagonabarraga, Núria,Caballol, Asuncion,Avila, Jinhui,Ding, Elena,García-Martín, Hortensia,Alonso-Navarro, Yaroslau,Compta, Carlos,Cruchaga, Katrin,Beyer, J Raphael,Gibbs, Andrew,Singleton, Sara,Bandres-Ciga, Pau,Pastor
NPJ genomic medicine · 2026-04-09
pmid:41957010
Pyramidal signs in Huntington's disease: An early clinical indicator associated with proximity to disease onset.
Xiao-Yan,Li, Yu-Feng,Bao, Chen-Chang,Hu, Yi,Dong, Zhi-Ying,Wu
Med (New York, N.Y.) · 2026-03-30
pmid:41916314
Inhibition of the NLRP3 Inflammasome With MCC950 Improves Gut Health in Huntington's Disease Mice.
Sujan Kumar,Sarkar, Millicent N,Ekwudo, Da,Lu, Bethany,Masson, Pamudika,Kiridena, Nicholas,van de Garde, Thibault,Renoir, James E,Vince, Veerasikku Gopal,Deepagan, Anthony J,Hannan, Carolina,Gubert
Journal of neurochemistry · 2026-04-01
pmid:41906693
Aberrant expression of the MID1 protein in neurons of Huntington's disease brain.
Adriana,Geraci, Annika,Reisbitzer, Janina,Gerhard, Sybille,Krauß
Frontiers in genetics · 2026-03-11
pmid:41884622